Oxurion NV (EBR:OXUR)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Vials	154.00K
Vials Growth	-65.16%
Royalties	109.00K
Royalties Growth	-28.76%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Belgium	263.00K
Belgium Growth	-55.80%